Dlgap1,

Kimino Minagawa1, Takashi Hayakawa2,3, Hayato Akimoto2,3

  • 1Division of Genomic Epidemiology and Clinical Trials, Clinical Trials Research Center, Nihon University School of Medicine, 30-1 Oyaguchi-Kamicho, Itabashi-ku, Tokyo, 173-8610, Japan. minagawa.kimino@nihon-u.ac.jp.

Psychopharmacology
|August 23, 2024
PubMed
概括

Dlgap1淘汰赛小鼠在年龄较大时发展出强迫症 (OCD) 类行为,包括过度理和焦虑. 在Dlgap1 KO小鼠中,弗卢沃胺治疗显著缓解了这些强迫症类型的表型.